会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • LITHIUM ION SECONDARY CELL
    • 锂离子二次电池
    • US20120202097A1
    • 2012-08-09
    • US13394909
    • 2010-08-11
    • Naoki KimuraTakenori Ishizu
    • Naoki KimuraTakenori Ishizu
    • H01M10/04H01M10/02H01M2/02
    • H01M10/0587H01M10/0525Y02T10/7011
    • In a lithium ion secondary cell including a wound group 20 in which a positive electrode 24 including a positive electrode mixture layer 5 and a negative electrode 22 including a negative electrode mixture layer 6 are wound with the interposition of separators 21, 23, a winding starting edge 22S is disposed more towards an inner peripheral side than the positive electrode 24; a winding ending edge 22E is disposed more towards an outer peripheral side than a winding ending edge 24E; the winding starting edges 24S, 22S, and the winding ending edges 24S, 22E are disposed within a flat portion of the wound group 20; and the negative electrode mixture layer 6 covering a surface of the positive electrode mixture layer 5 is disposed on an inner and an outer circumferential surface of the positive electrode mixture layer 5.
    • 在包括卷绕组20的锂离子二次电池中,其中包括正极合剂层5的正极24和包含负极混合物层6的负极22缠绕有隔离层21,23,绕组起始 边缘22S更靠近正极24的内周侧设置; 卷绕结束边缘22E比卷绕结束边缘24E更靠外侧设置; 卷绕起始边缘24S,22S和卷绕终止边缘24S,22E设置在卷绕组20的平坦部分内; 覆盖正极复合层5的表面的负极合剂层6配置在正极合剂层5的内周面和外周面上。
    • 10. 发明申请
    • Anti-pci neutralizing antibody
    • 抗pci中和抗体
    • US20060167230A1
    • 2006-07-27
    • US10542682
    • 2004-01-20
    • Takaki KogaNaoki KimuraTakeshi YoshinoKoichiro Ono
    • Takaki KogaNaoki KimuraTakeshi YoshinoKoichiro Ono
    • C07K16/44C07K16/40
    • C07K16/38C07K14/8121C07K2317/50C07K2317/565C07K2317/76C07K2317/92
    • The present invention provides anti-PCI antibodies having Protein C inhibitor (PCI)-neutralizing activity, and the uses thereof. Through the generation and screening of anti-PCI antibodies, the inventors successfully isolated anti-PCI antibodies which inhibit PCI's inhibitory effect on the production and activity of activated Protein C (aPC). The antibodies of the present invention suppress PCI's inhibitory effect on aPC production and/or the aPC inactivation by PCI, and thus can be used to maintain aPC activity and sustain the effects of aPC physiological activities, such as suppression of the activation of blood coagulation system and anti-inflammatory functions. The present invention also provides uses of the antibodies of the present invention in treating diseases such as thrombosis and sepsis using aPC. In treatments by aPC administration, the therapeutic effect of aPC can be sustained by administering an antibody of the present invention. The antibodies of the present invention can be used in the treatment and prevention of diseases such as thrombosis and sepsis.
    • 本发明提供具有蛋白C抑制剂(PCI) - 中和活性的抗PCI抗体及其用途。 通过抗PCI抗体的产生和筛选,本发明人成功地分离了抗PCI抗体,其抑制PCI对活化蛋白C(aPC)的产生和活性的抑制作用。 本发明的抗体抑制PCI对aPC生成的抑制作用和/或PCI的aPC失活,因此可用于维持aPC活性并维持aPC生理活性的作用,例如抑制血液凝固系统的活化 和抗炎功能。 本发明还提供了本发明的抗体在使用aPC治疗诸如血栓形成和败血症的疾病中的用途。 在通过aPC施用的治疗中,通过施用本发明的抗体可以维持aPC的治疗效果。 本发明的抗体可用于治疗和预防诸如血栓形成和败血症等疾病。